The expression of Fgl2 is significantly higher in many cancers, including colon cancer, oesophageal cancer, gastric cancer, breast cancer, lung cancer, and cervical cancer, but weakly expressed or not expressed in normal tissues adjacent to cancer 5. The gene discussed is FGL2; the disease is cancer.